Response to “Quantitative Clinical Pharmacology INPUT to SARS-CoV-2 Therapeutics Should be Based on Robust Data”

  1. Garcia-Cremades, M.
  2. Solans, B.P.
  3. Hughes, E.
  4. Ernest, J.P.
  5. Wallender, E.
  6. Savic, R.M.
Zeitschrift:
Clinical Pharmacology and Therapeutics

ISSN: 1532-6535,  0009-9236

Datum der Publikation: 2020

Ausgabe: 108

Nummer: 2

Seiten: 189

Art: Brief

DOI: 10.1002/CPT.1873 GOOGLE SCHOLAR lock_openOpen Access editor
Datenquelle: Scopus